Global Blood Therapeutics Appoints Ted W. Love, M.D., to the Company’s Board of Directors
Published: Sep 19, 2013
Global Blood Therapeutics, a product-focused company developing novel, orally-available therapeutics for chronic blood diseases, today announced the appointment of Ted W. Love, M.D., to the company’s board of directors. Dr. Love most recently served as executive vice president, research and development and technical operations at Onyx Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.